These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 12700498)
1. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?]. Thiéfin G Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498 [TBL] [Abstract][Full Text] [Related]
2. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin? Chan FK Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550 [TBL] [Abstract][Full Text] [Related]
3. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
5. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?]. Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802 [TBL] [Abstract][Full Text] [Related]
6. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users? Sung JJ Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():65-70. PubMed ID: 15335415 [TBL] [Abstract][Full Text] [Related]
7. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy? McCarthy DM Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355 [TBL] [Abstract][Full Text] [Related]
10. [Significance of H. pylori eradication in treatment and prevention for low-dose aspirin induced gastric ulcer of elderly]. Kato M; Ono S; Yoshida T; Mabe K; Shimizu Y; Asaka M Nihon Rinsho; 2010 Nov; 68(11):2089-95. PubMed ID: 21061538 [TBL] [Abstract][Full Text] [Related]
11. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715 [TBL] [Abstract][Full Text] [Related]
12. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106 [TBL] [Abstract][Full Text] [Related]
13. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL; Huang B; Amer F; Christopoulos NG Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa. Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features and diagnosis of non-steroidal anti-inflammatory drugs induced ulcers of the stomach]. Watari J; Kim Y; Yokoyama S; Hori K; Miwa H Nihon Rinsho; 2011 Jun; 69(6):1016-23. PubMed ID: 21688621 [TBL] [Abstract][Full Text] [Related]
16. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
17. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy. Cherian PT; Cherian S; Singh P Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640 [TBL] [Abstract][Full Text] [Related]
19. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid]. Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039 [TBL] [Abstract][Full Text] [Related]
20. [What role today for Helicobacter pylori in peptic ulcer?]. Cadiot G Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]